BQST · Bioquest Corp · Executive Compensation
$0.25
At close · Oct 14
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 12, 2022
Substantial doubt about the company's ability to continue as a going concern.
“As reflected in the accompanying financial statements, the Company had an accumulated deficit as of July 31, 2022, of $10,788,321 and its liabilities exceeded its assets by $536,419 These factors among others raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Sep 12, 2022
Market Cap
$7.47M
Shares
29.90M
Volume · Oct 14
67.47K
Avg daily vol (3 sessions)
22.69K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Leadership
- Geoffrey P. Mott CEO
- Thomas Hemingway CEO, Chairman, Board Member
- David Noyes CFO
- Mike Krall COO, Board Member
- Christian Trudeau Board Member
- Eric Gareau Board Member
- Jeff Donnell Board Member
- Jeffery Donnell Board Member
- Michael Krall Board Member
- Philippe Germain Board Member
- Robert Orbach Board Member